Poll results: Did you purchase new equipment during COVID-19?

Article

See our latest poll results

Optometry Times® polled our audience with the following question from April 30, 2021 to May 14, 2021:​ Did you purchase new equipment during COVID-19?

The poll appeared on optometrytimes.com and was promoted on various social media channels. Results show a majority of responding ODs purchased a new diagnostic device during COVID-19.

30 ODs responded, in total. Of these:

• 20 reported purchasing a new diagnostic device

• 2 reported purchasing a new therapeutic device

• 1 reported purchasing new software

• 7 reported making no purchases

Recent Videos
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Alysse Henkel, vice president of Research and inSights at The Vision Council, advised that expanding budget and mid-market frame options may help improve frames sales.
Steven T. Reed, OD, American Optometric Association's president, overviews the 2024 highlights and how the organization plans to extend success into 2025.
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Danielle Crull, ABOM, and Truffles of A Child's Eyes talk pediatric eye health and initiatives
© 2025 MJH Life Sciences

All rights reserved.